CUSIP No. G59665102
AMENDMENT NO. 1 TO SCHEDULE 13G
Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Ordinary Shares of the Issuer on March 4, 2019 (the “Schedule 13G”). Terms defined in the Schedule 13G are used herein as so defined.
The following items of the Schedule 13G are amended and restated to read in their entirety as follows:
Item 1(b). Address of Issuer’s Principal Executive Offices
450 East 29th Street, 14th Floor, New York, NY 10016
Item 2(a). Name of Person Filing
This statement is being filed by Johnson & Johnson, a New Jersey corporation (“J&J”), and Johnson & Johnson Innovation-JJDC, Inc., a New Jersey corporation (“JJDC”) (together, the Reporting Persons”). JJDC is a wholly-owned subsidiary of J&J. The securities reported herein as being held by J&J and JJDC are directly beneficially owned by JJDC. J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC. The Joint Filing Agreement between the Reporting Persons is attached hereto as Exhibit 1.
Item 4. Ownership
The information requested in this item is incorporated herein by reference to the cover pages to this Amendment No. 1 to Schedule 13G. Ownership percentage is based on 48,468,192 Ordinary Shares outstanding as of November 9, 2022, consisting of (i) 44,725,678 Ordinary Shares outstanding as of October 31, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q for the period ended September 30, 2022 filed with the Securities and Exchange Commission on November 10, 2022, and (ii) 3,742,514 Ordinary Shares issued to JJDC in a private placement that closed on November 9, 2022
Item 10. Certification
By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
4